State-accredited CME providers continue to decrease, with 68 dropping out as of last year, but so far the trend has not posed a threat to physician education, one official says.
In a sign of industry’s ongoing desire to broaden its CME funding outlook, a couple of programs recently supported by Pfizer aim to foster practice-based improvement as they seek to advance the science of CME.
Piercing the veil, but missing the value of medicine’s industry ties
ProPublica’s Dollars for Docs database has grown richer in pharma company payments but falls short in putting context around those expenditures, say industry-side critics.
Glaxo signage touts firm’s drug-testing role in ’12 Games
GlaxoSmithKline got help from British olympian Rebecca Romero in unfurling new signage at its London headquarters today. The sign plays up Glaxo’s commitment to keeping the 2012 London Olympic and Paralympic Games drug free.
Assertions that challenge the American Medical Association’s commitment to its data-mining alternative are “unfounded speculation that ignores the facts,” said AMA president Dr. Peter Carmel.